ROSEN, SKILLED INVESTOR COUNESL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm
New York, New York--(Newsfile Corp. - May 27, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the 'Registration Statement') issued in connection with Zenas BioPharma's September 2024 initial public offering ('IPO' or the 'Offering'), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the firm.
SO WHAT: If you purchased Zenas BioPharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Zenas BioPharma class action, go to https://rosenlegal.com/submit-form/?case_id=37109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Zenas BioPharma action, go to https://rosenlegal.com/submit-form/?case_id=37109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/253541
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
15 minutes ago
- Forbes
No Pipeline, No Progress: Meeting The Demand For Advanced Degrees
As demand for master's and doctoral degrees surges, too few programs exist to support the students most often excluded—despite their potential. The United States stands at a crossroads. While innovation, competitiveness, and global leadership increasingly depend on highly educated workers, access to graduate education remains deeply unequal and underfunded. Over 60% of business and government leaders hold graduate degrees—with more than half in business and nearly a third in law. A 2020 report by Brint and colleagues found that 61% of top media figures and 78% of think tank and foundation leaders also held advanced degrees. In many leadership roles, graduate education is no longer a competitive advantage—it's a requirement. Demand is rising. A 2024 report from Georgetown University's Center on Education and the Workforce projects that nearly 1 in 5 jobs will soon require an advanced degree. Among 'good jobs'—those offering middle-class wages of $43,000 or more—1 in 4 will demand graduate credentials. Yet access to graduate education remains deeply inequitable. Madeline Brighouse Glueck finds that parental education still shapes graduate enrollment, especially in high-investment, high-return programs like law, medicine, and PhDs. In medicine alone, over 75% of students come from the top two income quintiles. Even academically qualified first-generation and low-income students are often left behind. While families with financial and social capital can navigate elite admissions and cover soaring costs, others are shut out. The only federally funded graduate pipeline program is the McNair Scholars Program, which supports first-generation, low-income, and underrepresented undergraduates seeking PhDs. This program—and others like Upward Bound—are now at risk of being defunded. As the federal government grows increasingly hostile toward identity-based programs in higher education, the burden of promoting equitable access is falling to the private sector and nonprofit organizations. Yet only a handful of national nonprofits directly focus on this issue: These organizations are doing powerful work—but their combined reach can only serve a fraction of the students who deserve access. To meet the moment, coordinated investments are needed—not just in graduate preparation, but also in affordability, mentorship, and long-term support: Graduate education is not a luxury—it is a national imperative. If we want to lead in science, health, law, and business—and if we believe in opportunity—we must invest in the people who will lead those fields. Let's ensure that talent, not zip code or family background, determines who has a seat at the table. Change can't wait. The time to invest is now. —--------- Help us widen the pipeline. Support Leadership Brainery in creating equitable pathways to graduate education. Donate today!
Motor Trend
16 minutes ago
- Motor Trend
The Cheapest Pickup Trucks You Can Buy in 2025 Aren't All Small
Almost across the board, pickup truck prices are creeping upward. Most of this is due to inflation (and more recently, tariffs), but formerly cheap trucks like the new generation Toyota Tacoma are going somewhat upmarket, while the price creep affecting the cheapest pickups like the Ford Maverick appears to be due to automakers capitalizing on unexpected success and, again, more recently, responding to tariffs. (The Maverick, like some other trucks on this list, is assembled outside of the U.S., which raises price pressure compared to home built options.) For now, the cheapest work trucks you can buy can still be had for under $40,000, but you don't need us to tell you that the versions of the most common full-size trucks most consumers buy are in the $50,000 to $60,000 range. Of course, the base price isn't the only metric by which to measure a truck, but it's an important one. If you want to explore other ways pickup trucks stack up against each other, MotorTrend 's proprietary algorithm provides the ultimate source of automotive data by combining over 75 years of our own instrumented performance, comfort, and efficiency testing on more than 5,000 vehicles. That data is fused with decades of expertise from former heads of design, engineering, and our own car buying experience experts. Built by statisticians and honed by automotive experts, MotorTrend 's Ultimate Car Rankings will assist in finding your perfect vehicle. But, you came here for cheap trucks, and here they are, the cheapest trucks you can buy in 2025:
Fox News
19 minutes ago
- Fox News
WATCH LIVE: Unite for Veterans, Unite for America rally on the National Mall
All times eastern Making Money with Charles Payne FOX News Radio Live Channel Coverage WATCH LIVE: Unite for Veterans, Unite for America rally on the National Mall
